About KaliVir Immunotherapeutics
multiple therapies, one virus.KALIVIR is developing cutting edge, next-generation oncolytic viral immunotherapy programs for treatment of cancer.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Undisclosed
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
kalivir.com
Domain Registered Date
Jun 19, 2019
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $14,000,000 · Series-A
fundraisingfox.com
- Milestone
X account created (@kalivir_immuno)
74 followers
- Milestone
Website domain registered
kalivir.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for KaliVir Immunotherapeutics.
Funding History
Series-A
· Aug 19, 2026
$14,000,000 fundraisingfox.com
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026